Steven F. Bellon - 24 Jan 2024 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Scientific Officer
Signature
/s /Tara Maduri, Attorney-in-Fact for Steven F. Bellon
Issuer symbol
FHTX
Transactions as of
24 Jan 2024
Net transactions value
+$336,600
Form type
4
Filing time
25 Jan 2024, 16:02:33 UTC
Previous filing
30 Jan 2023
Next filing
11 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $336,600 +110,000 $3.06 110,000 24 Jan 2024 Common Stock 110,000 $3.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.